Cetaphil AI Visibility Market Strategy Report - Dermatologist Recommended Skin Care Brands

Answer Capsule

Cetaphil is visible in AI-generated recommendations for dermatologist-recommended skin care brands but converts that presence into shortlist positions at a much lower rate than the category leaders. In October 2026, Cetaphil recorded a 59.48% valid recommendation coverage rate, ranking fourth of ten tracked brands, well behind CeraVe at 94.55% and La Roche-Posay at 92.86%. The brand's clearest strength is a stable, positive framing profile with a 0.9665 net sentiment score and zero negative mentions. Its clearest weakness is weak first-position recommendation power: a 3.38% rank-one rate against CeraVe's 54.94%. The clearest opportunity is converting its broad consideration-stage presence into top-three and first-choice placement inside the Brand Recommendation cluster.

Who This Report Is For

This report is for Cetaphil brand, marketing, and ecommerce leaders who need to understand how AI search and assistant platforms recommend dermatologist-recommended skin care brands, and where Cetaphil is being displaced in the buyer shortlist.

Report Card

Executive Summary

Questions This Section Answers

• Where does Cetaphil rank among dermatologist-recommended skin care brands in AI recommendations?
• How much of a gap is there between Cetaphil's AI presence and its first-position recommendations?
• Which platforms show the strongest and weakest signals for Cetaphil?

Cetaphil holds a mid-tier position in AI-generated recommendations for dermatologist-recommended skin care brands. The October 2026 benchmark recorded 477 mentions across 770 qualified observations, a 61.95% raw mention presence rate, and 458 valid recommendations, a 59.48% valid recommendation coverage rate. That places Cetaphil fourth of ten tracked brands, behind CeraVe (94.55%), La Roche-Posay (92.86%), and Vanicream (73.12%), and ahead of Neutrogena (50.26%), Aveeno (40.52%), EltaMD (31.82%), SkinCeuticals (31.69%), Eucerin (27.66%), and Differin (7.53%).

The gap between presence and recommendation is modest but meaningful. Cetaphil appears in 61.95% of qualified observations and is recommended in 59.48%, a difference of 2.47 points. That is a tighter conversion than some lower-ranked brands, but it sits far below the category leaders. CeraVe converts 96.75% presence into 94.55% recommendation coverage, and La Roche-Posay converts 94.55% into 92.86%.

Cetaphil's strongest cluster is the Brand Recommendation cluster, the only cluster with qualified data in the October 2026 public series. Within that cluster, Cetaphil recorded a 30.52% top-three rate and a 3.38% rank-one rate. The brand is being shortlisted in roughly three of every ten qualified observations but is named first in only about three of every hundred.

The weakest signal is first-position recommendation power. Cetaphil's 3.38% rank-one rate is the fourth-lowest in the category, ahead of only Neutrogena (1.30%), Eucerin (0.39%), and Differin (0.26%). Even brands with lower overall coverage, such as EltaMD at 2.99% and Aveeno at 2.34%, sit close to Cetaphil on this metric. The brand is present and recommended, but rarely as the first choice.

The strongest platform signal for Cetaphil is Gemini, where the brand recorded a 69.15% valid recommendation coverage rate and a 6.38% rank-one rate, both above its overall averages. The weakest platform signal is ChatGPT, where Cetaphil recorded a 55.56% valid recommendation coverage rate and a 0.00% rank-one rate. On ChatGPT, Cetaphil was recommended in the top three in 16.67% of observations but never as the first recommendation.

The clearest platform gap is the rank-one rate on ChatGPT and Google AI Overviews. On ChatGPT, Cetaphil received zero first-position recommendations across 90 observations. On Google AI Overviews, the brand recorded a 3.61% rank-one rate across 194 observations. These are the two platforms where Cetaphil's first-choice weakness is most pronounced.

The category context matters. The benchmark recorded a 98.6% valid recommendation shortlist share in October 2026, meaning nearly every qualified observation produced a recommendation-shaped answer. AI systems are actively recommending brands in this vertical, and Cetaphil is being included in those shortlists at a moderate rate. The question is not whether Cetaphil appears, but whether it appears first.

What Cetaphil Is Winning

Questions This Section Answers

• What are Cetaphil's strongest metrics in the October 2026 AI visibility benchmark?
• On which AI platform does Cetaphil perform best for recommendation coverage and first-position placement?

Cetaphil's clearest win is its sentiment and framing profile. The brand recorded 461 positive mentions, 16 neutral mentions, and zero negative mentions across 770 qualified observations, producing a net sentiment score of 0.9665. That is the fourth-highest sentiment score in the category, behind Vanicream (0.9930), La Roche-Posay (0.9863), and CeraVe (0.9826). No AI platform surfaced a negative framing of Cetaphil in the October 2026 dataset.

The brand's second win is its Gemini performance. On Gemini, Cetaphil recorded a 69.15% valid recommendation coverage rate, a 28.72% top-three rate, and a 6.38% rank-one rate across 94 observations. All three metrics exceed Cetaphil's overall averages. Gemini is the platform where Cetaphil is most likely to be recommended and most likely to be named first.

The brand's third win is its stable presence in the Brand Recommendation cluster. Cetaphil appeared in 477 of 770 qualified observations, a 61.95% presence rate. That is the fourth-highest presence rate in the category, behind CeraVe (96.75%), La Roche-Posay (94.55%), and Vanicream (73.77%). The brand is consistently visible in AI-generated answers about dermatologist-recommended skin care.

These wins are real but narrow. Cetaphil is not the category leader on any single metric. It is a consistent mid-tier performer with strong sentiment and a notable Gemini advantage.

Where Cetaphil Has the Clearest AI Visibility Gaps

Questions This Section Answers

• What is Cetaphil's biggest weakness in AI-generated brand recommendations?
• How does Cetaphil's first-position rate compare to CeraVe, La Roche-Posay, and Vanicream?
• Which platforms show the largest gaps in Cetaphil's rank-one recommendation rate?

The clearest gap is first-position recommendation power. Cetaphil's 3.38% rank-one rate means the brand is named first in approximately 26 of 770 qualified observations. CeraVe, by contrast, recorded 423 first-position recommendations, a 54.94% rank-one rate. La Roche-Posay recorded 141, an 18.31% rate. Vanicream recorded 57, a 7.40% rate. Cetaphil's first-choice share is closer to EltaMD (2.99%) and Aveeno (2.34%) than to the brands it competes with for shortlist positions.

The second gap is top-three placement. Cetaphil's 30.52% top-three rate places it fourth in the category, behind CeraVe (81.95%), La Roche-Posay (70.78%), and Vanicream (32.47%). The brand is recommended in the top three in roughly 235 of 770 qualified observations. That is a meaningful shortlist presence, but it is less than half of La Roche-Posay's top-three rate and less than two-fifths of CeraVe's.

The third gap is platform inconsistency. Cetaphil's rank-one rate varies sharply by platform. On Gemini, the brand recorded a 6.38% rank-one rate. On Perplexity, 7.37%. On Copilot, 2.06%. On Google AI Mode, 2.00%. On Google AI Overviews, 3.61%. On ChatGPT, 0.00%. The ChatGPT result is the most striking: across 90 observations, Cetaphil was never the first recommendation. The brand was recommended in the top three in 15 observations, a 16.67% top-three rate, but never at the top position.

The fourth gap is the comparison to Vanicream. Vanicream recorded a 73.12% valid recommendation coverage rate and a 32.47% top-three rate in October 2026, both above Cetaphil's figures. Vanicream also recorded a 7.40% rank-one rate, more than double Cetaphil's 3.38%. The benchmark identified Vanicream as the largest cumulative riser of the tracking period, up 8.4 points from July 2026. Cetaphil declined 3.8 points over the same period, from 63.3% to 59.5%. The gap between the two brands is widening.

Biggest Opportunity

Questions This Section Answers

• What specific conversion problem should Cetaphil focus on to improve its AI visibility?
• Which platforms represent the biggest opportunities for moving Cetaphil from shortlist to first position?

Cetaphil's biggest opportunity is converting its broad consideration-stage presence into first-position recommendations inside the Brand Recommendation cluster. The brand already appears in 61.95% of qualified observations and is recommended in 59.48%. The conversion from presence to recommendation is not the problem. The problem is the conversion from recommendation to first choice.

The benchmark data shows that Cetaphil is being shortlisted alongside CeraVe, La Roche-Posay, and Vanicream but is rarely named first. On ChatGPT, the brand received zero first-position recommendations across 90 observations. On Google AI Overviews, the brand received seven first-position recommendations across 194 observations. These are the two platforms with the largest observation counts in the dataset, and they are the platforms where Cetaphil's first-choice weakness is most pronounced.

The opportunity is to identify the specific prompt patterns and answer structures where Cetaphil is being recommended but not prioritized, and to build the owned answer layer, citation support, and framing quality needed to move the brand into first position. This is a recommendation-stage visibility problem, not a presence problem.

Competitive Landscape

Questions This Section Answers

• How do CeraVe, La Roche-Posay, Vanicream, and Cetaphil compare on top-three and rank-one recommendation rates?
• What does the gap between Cetaphil's top-three rate and rank-one rate reveal about its competitive position?

CeraVe and La Roche-Posay hold dominant recommendation-stage strength in the dermatologist-recommended skin care category, with CeraVe leading on every major metric and La Roche-Posay a close second. Vanicream is the strongest challenger, with a 73.12% valid recommendation coverage rate and a 32.47% top-three rate. Cetaphil sits fourth, visible and recommended but rarely named first.

Average recommended rank covers rank-eligible recommendations only.

Cetaphil's fourth-place position on top-three rate and its fourth-place position on rank-one rate show a brand that is consistently shortlisted but rarely prioritized. The gap between its 30.52% top-three rate and its 3.38% rank-one rate is 27.14 points, the largest such gap among the top four brands. CeraVe's gap is 27.01 points, La Roche-Posay's is 52.47 points, and Vanicream's is 25.07 points. Cetaphil is being recommended in the top three at a rate similar to Vanicream but is named first at less than half Vanicream's rate.

Prompt Evidence

Questions This Section Answers

• Which specific prompts reveal Cetaphil's platform-level visibility and first-position weaknesses?
• On which prompts does Cetaphil receive zero first-position recommendations despite being mentioned?

ChatGPT / Brand Recommendation Prompt: "What are the top 10 best skincare brands?" Result: Cetaphil was mentioned and recommended in the top three in some observations but received zero first-position recommendations across 90 ChatGPT observations.

Gemini / Brand Recommendation Prompt: "What do dermatologists recommend for facial cleanser?" Result: Cetaphil recorded its strongest platform performance on Gemini, with a 69.15% valid recommendation coverage rate and a 6.38% rank-one rate.

Google AI Overviews / Brand Recommendation Prompt: "Which is the best moisturizer to use?" Result: Cetaphil was recommended in 108 of 194 observations, a 55.67% valid recommendation coverage rate, but was named first in only seven observations, a 3.61% rank-one rate.

Perplexity / Brand Recommendation Prompt: "What are the top skincare brands?" Result: Cetaphil recorded a 65.26% valid recommendation coverage rate and a 7.37% rank-one rate, its second-strongest platform performance.

What CiteWorks Studio Would Do Next

Phase 1: AI Visibility Market Discovery Audit Map Cetaphil's prompt-level visibility across all six AI platforms, identifying the specific questions where the brand is recommended but not prioritized, and the competitors that appear ahead of it.

Phase 2: Recommendation Readiness Plan Prioritize the prompt clusters and platform gaps where Cetaphil's first-position weakness is most pronounced, starting with ChatGPT and Google AI Overviews.

Phase 3: Owned Answer Layer Buildout Develop owned content and structured answers that address the high-intent prompts where Cetaphil is being shortlisted but not named first, with a focus on the Brand Recommendation cluster.

Phase 4: Citation / Authority Layer Development Strengthen the public evidence layer that AI systems retrieve and synthesize, including editorial, retail, and community sources that shape recommendation-stage answers in this vertical.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Cetaphil's presence, recommendation coverage, top-three rate, rank-one rate, and sentiment month over month, with a focus on closing the gap to Vanicream and the category leaders.

Why This Matters

Questions This Section Answers

• Why does presence alone not guarantee brand success in AI-generated recommendations for skin care?
• What does Cetaphil's rank-one rate mean for its commercial visibility in AI-powered search?

AI-generated recommendations are becoming a primary discovery surface for dermatologist-recommended skin care brands. The October 2026 benchmark recorded a 98.6% valid recommendation shortlist share, meaning nearly every qualified observation produced a recommendation-shaped answer. Buyers asking AI systems for the best skincare brands, the best moisturizer, or the best cleanser for sensitive skin are receiving shortlists that include Cetaphil but rarely place it first.

Presence alone is not enough. Cetaphil appears in 61.95% of qualified observations and is recommended in 59.48%, but it is named first in only 3.38%. The brand is in the room but not at the head of the table. The next move is targeted correction of the prompt, page, and citation layers that determine whether Cetaphil is recommended first or recommended fourth.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

Cetaphil's sentiment score for October 2026 is 0.9665. The brand recorded 461 positive mentions, 16 neutral mentions, and zero negative mentions across 477 total mentions. The score is calculated as (461 × 1 + 16 × 0 + 0 × -1) / 477 = 0.9665.

This matters because unclassified mention counts are misleading. A brand that appears in 477 observations but is framed negatively in half of them is not in the same position as a brand with 477 mentions and zero negative framing. Cetaphil's zero negative mentions is a genuine strength. The brand is not being cautioned against or compared unfavorably in AI-generated answers.

Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal. Cetaphil's 461 positive mentions and 16 neutral mentions indicate that AI systems are framing the brand favorably when they mention it. The challenge is not sentiment. The challenge is placement.

Counting all mentions as wins is bad measurement. Cetaphil's 477 mentions include 458 valid recommendations and 19 mentions that were not valid recommendations. The brand's 59.48% valid recommendation coverage is the metric that matters for shortlist eligibility. Classified sentiment is required before interpreting AI visibility, and Cetaphil's sentiment profile is strong.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Cetaphil's AI visibility and recommendation performance in the dermatologist-recommended skin care category. It is not a client implementation case study and does not imply that CiteWorks Studio caused any benchmark outcome.
2. The reporting month is October 2026. The benchmark baseline is July 2026. Intermediate months August 2026 and September 2026 are referenced where the source data provides them.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode. Platform-level metrics are reported only where the dataset contains observations for that platform.
4. The October 2026 benchmark analyzed 770 qualified observations. The raw collection included 800 prompt-surface observations, 666 unique questions, and 800 brand or competitor mentions. After qualification, 770 observations remained.
5. Ten brands were tracked: CeraVe, La Roche-Posay, Vanicream, Cetaphil, Neutrogena, Aveeno, EltaMD, SkinCeuticals, Eucerin, and Differin.
6. The public benchmark series for October 2026 contains qualified observations in one buyer-intent cluster: Brand Recommendation. The Pricing & Value and Multi-Brand Comparison clusters recorded zero qualified observations in the public series. This report cannot answer which brand wins a direct head-to-head comparison or whether price influences AI recommendations.
7. Stage 0 extraction produced the prompt-level observations used in this report, covering query, AI surface, recommendation outcome, rank, sentiment, and citations where exposed.
8. A mention is defined as any appearance of Cetaphil in an AI-generated answer to a qualified observation. A valid recommendation is defined as an observation where Cetaphil appeared in a valid recommendation shortlist. Mentions that were neutral, cautionary, or listed only were not counted as valid recommendations unless the dataset explicitly marked them as such.
9. Top-three rate is the share of qualified observations where Cetaphil was recommended in the top three positions. Rank-one rate is the share of qualified observations where Cetaphil was the first or only recommendation. Average recommended rank covers rank-eligible recommendations only.
10. The dataset contains modeled monetary metrics. Those metrics are omitted from this report. Counts, percentages, ranks, and sentiment scores are reported as provided.
11. The benchmark records change rather than explaining it. Month-over-month movement identifies changes worth investigating and does not by itself establish causation.
12. Source presence in the benchmark is evidence about the information environment, not automatic proof that a source caused a recommendation. The top 10 cited domains in October 2026 included google.com, allure.com, youtube.com, amazon.com, nbcnews.com, reddit.com, nytimes.com, byrdie.com, instagram.com, and target.com. No tracked brand's own domain appeared in the top 10.

See How AI Is Recommending Your Brand

Cetaphil is visible in AI-generated recommendations for dermatologist-recommended skin care brands, but the brand is rarely named first. A company-level AI visibility audit maps the specific prompts, platforms, and competitor displacement patterns that determine whether Cetaphil is recommended first or recommended fourth. The audit turns the benchmark's directional signals into a prioritized action plan for closing the gap to CeraVe, La Roche-Posay, and Vanicream.